Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
BOSTON, April 10, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.
波士顿，2024年4月10日 /PRNewswire/ — Haemonetics Corporation（纽约证券交易所代码：HAE）宣布，该公司打算在美国东部时间2024年5月9日星期四上午6点公布第四季度和2024财年的财务业绩。该公司将在美国东部时间2024年5月9日上午8点与投资者和分析师举行电话会议，讨论业绩并回答问题。
The call can be accessed via teleconference at: Q4 2024 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
该电话会议可通过电话会议接听：Haemonetics Corporation 2024 年第四季度业绩电话会议。注册完成后，参与者将收到一个拨入号码以及用于接听电话的个性化密码。虽然不是必需的，但建议参与者在活动开始前 10 分钟加入。
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:
电话会议的网络直播可在Haemonetics的投资者关系网站上观看。网络直播链接：
A replay of the conference call and webcast will be available for one year beginning on May 9, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.
使用本新闻稿中提供的电话会议网络直播链接，电话会议和网络直播的重播将从美国东部时间2024年5月9日上午11点开始，为期一年。
About Haemonetics
关于 Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit .
Haemonetics（纽约证券交易所代码：HAE）是一家全球医疗保健公司，致力于为客户提供一系列创新的医疗产品和解决方案，帮助他们改善患者护理并降低医疗保健成本。我们的技术适用于重要的医疗市场：血液和血浆成分采集、手术套件和医院输血服务。要了解有关 Haemonetics 的更多信息，请访问。
|
Investor Contacts: | |
|
Olga Guyette, Sr. Director-Investor Relations & Treasury |
David Trenk, Manager-Investor Relations |
|
(781) 356-9763 |
(203) 733-4987 |
|
[email protected] |
[email protected] |
|
Media Contact: | |
|
Josh Gitelson, Director-Global Communications | |
|
(781) 356-9776 | |
|
[email protected] |
|
投资者联系方式： | |
|
Olga Guyette，投资者关系和财政部高级总监 |
大卫·特伦克，投资者关系经理 |
|
(781) 356-9763 |
(203) 733-4987 |
|
[电子邮件保护] |
[电子邮件保护] |
|
媒体联系人： | |
|
乔什·吉特尔森，全球传播总监 | |
|
(781) 356-9776 | |
|
[电子邮件保护] |
SOURCE Haemonetics Corporation
来源 Haemonetics 公司